These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 9737547)

  • 1. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy.
    Umehara F; Okada Y; Fujimoto N; Abe M; Izumo S; Osame M
    J Neuropathol Exp Neurol; 1998 Sep; 57(9):839-49. PubMed ID: 9737547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue inhibitor of metalloproteinase 3, matrix metalloproteinase 9, and neopterin in the cerebrospinal fluid: preferential presence in HTLV type I-infected neurologic patients versus healthy virus carriers.
    Lezin A; Buart S; Smadja D; Akaoka H; Bourdonné O; Perret-Liaudet A; Césaire R; Belin MF; Giraudon P
    AIDS Res Hum Retroviruses; 2000 Jul; 16(10):965-72. PubMed ID: 10890358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIMPs and MMPs expression in CSF from patients with TSP/HAM.
    Kettlun AM; Cartier L; García L; Collados L; Vásquez F; Ramírez E; Valenzuela MA
    Life Sci; 2003 May; 72(25):2863-76. PubMed ID: 12697269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T lymphocytes activated by persistent viral infection differentially modify the expression of metalloproteinases and their endogenous inhibitors, TIMPs, in human astrocytes: relevance to HTLV-I-induced neurological disease.
    Giraudon P; Szymocha R; Buart S; Bernard A; Cartier L; Belin MF; Akaoka H
    J Immunol; 2000 Mar; 164(5):2718-27. PubMed ID: 10679113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Increased activity of metalloproteinases and their inhibitors in cerebrospinal fluid of patients with tropical spastic paraparesis].
    Valenzuela MA; Collados L; Kettlun AM; González F; Cartier L
    Rev Med Chil; 2000 Jun; 128(6):585-92. PubMed ID: 11016056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal lesions and widespread involvement of white matter associated with multi-organ inflammatory disease in human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Mendes GB; Kalil RS; Rosadas C; de Freitas MR; Puccioni-Sohler M
    Int J Infect Dis; 2014 Aug; 25():1-3. PubMed ID: 24815740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of matrix metalloproteinases at the bone-implant interface in loose total hip replacements.
    Yokohama Y; Matsumoto T; Hirakawa M; Kuroki Y; Fujimoto N; Imai K; Okada Y
    Lab Invest; 1995 Dec; 73(6):899-911. PubMed ID: 8558853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective matrix metalloproteinase inhibitor, N-biphenyl sulfonyl phenylalanine hydroxamic acid, inhibits the migration of CD4+ T lymphocytes in patients with HTLV-I-associated myelopathy.
    Ikegami M; Umehara F; Ikegami N; Maekawa R; Osame M
    J Neuroimmunol; 2002 Jun; 127(1-2):134-8. PubMed ID: 12044984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukoencephalopathy in HTLV-I-associated myelopathy/tropical spastic paraparesis: MRI analysis and a two year follow-up study after corticosteroid therapy.
    Kira J; Fujihara K; Itoyama Y; Goto I; Hasuo K
    J Neurol Sci; 1991 Nov; 106(1):41-9. PubMed ID: 1779238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of metalloproteinase-2 (gelatinase A) in labial salivary glands of patients with Sjögren's syndrome with HTLV-I infection.
    Tominaga M; Migita K; Nakamura H; Ichinose Y; Furuya T; Origuchi T; Kawabe Y; Hida A; Nakamura T; Eguchi K
    Clin Exp Rheumatol; 1999; 17(4):463-6. PubMed ID: 10464559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokines secreted by glial cells infected with HTLV-I modulate the expression of matrix metalloproteinases (MMPs) and their natural inhibitor (TIMPs): possible involvement in neurodegenerative processes.
    Giraudon P; Buart S; Bernard A; Belin MF
    Mol Psychiatry; 1997 Mar; 2(2):107-10, 84. PubMed ID: 9106228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury.
    Rosenberg GA; Dencoff JE; Correa N; Reiners M; Ford CC
    Neurology; 1996 Jun; 46(6):1626-32. PubMed ID: 8649561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visualization of HTLV-1-specific cytotoxic T lymphocytes in the spinal cords of patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Matsuura E; Kubota R; Tanaka Y; Takashima H; Izumo S
    J Neuropathol Exp Neurol; 2015 Jan; 74(1):2-14. PubMed ID: 25470342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trophic factors in cerebrospinal fluid and spinal cord of patients with tropical spastic paraparesis, HIV, and Creutzfeldt-Jakob disease.
    Albrecht D; García L; Cartier L; Kettlun AM; Vergara C; Collados L; Valenzuela MA
    AIDS Res Hum Retroviruses; 2006 Mar; 22(3):248-54. PubMed ID: 16545011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-induced metalloproteinase-9 production is associated with neurological manifestations in HTLV-1-infected individuals.
    Guerra M; Carvalho NB; Santos S; Nascimento MT; Sá R; Carvalho AM; Carvalho EM; Carvalho LP
    Front Immunol; 2022; 13():954103. PubMed ID: 36311773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas.
    Nomura H; Fujimoto N; Seiki M; Mai M; Okada Y
    Int J Cancer; 1996 Feb; 69(1):9-16. PubMed ID: 8600068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometry evaluation of the T-cell receptor Vbeta repertoire among human T-cell lymphotropic virus type-1 (HTLV-1) infected individuals: effect of interferon alpha therapy in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Saito M; Nose H; Usuku K; Sabouri AH; Matsuzaki T; Izumo S; Arimura K; Osame M
    J Neurol Sci; 2006 Jul; 246(1-2):37-43. PubMed ID: 16545396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of adhesion molecules and monocyte chemoattractant protein -1 (MCP-1) in the spinal cord lesions in HTLV-I-associated myelopathy.
    Umehara F; Izumo S; Takeya M; Takahashi K; Sato E; Osame M
    Acta Neuropathol; 1996; 91(4):343-50. PubMed ID: 8928610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of myelin basic protein in cerebrospinal fluid and serum from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Ohta M; Ohta K; Nishimura M; Saida T
    Ann Clin Biochem; 2002 Nov; 39(Pt 6):603-5. PubMed ID: 12564844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.